6.  Occurrence of solicited local and systemicreactogenicity signs and symptoms for 7 daysfollowing vaccination7.  Occurrence of unsolicited adverse eventsfor 28 days following vaccination8.  Occurrence of serious adverse eventsthroughout participants’ participation in thetrial- Frequency of influenza-specific T-cellsmeasured by IFN-γ ELISpot- Geometric mean titre of influenza-specificneutralising antibodies- Breadth of influenza-specific T-cells andantibodies1.  Incidence rate of laboratory confirmedinfluenza using RT-PCR. Here, IFNG is linked to influenza.